WNT5A Human shRNA Plasmid Kit (Locus ID 7474)
CAT#: TL320572
WNT5A - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (4)
Lateral flow testing sticks used for the semi-quantitative detection of the lentiviral p24 protein, 20 tests
CNY 4,070.00
Specifications
Product Data | |
Product Name | WNT5A Human shRNA Plasmid Kit (Locus ID 7474) |
Locus ID | 7474 |
UniProt ID | P41221 |
Synonyms | hWNT5A |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | WNT5A - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 7474). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001256105, NM_003392, NM_003392.1, NM_003392.2, NM_003392.3, NM_003392.4, NM_001256105.1, BC064694, BC064694.1, BC074783, BM728706, NM_003392.7 |
Summary | The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene encodes a member of the WNT family that signals through both the canonical and non-canonical WNT pathways. This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2. This protein plays an essential role in regulating developmental pathways during embryogenesis. This protein may also play a role in oncogenesis. Mutations in this gene are the cause of autosomal dominant Robinow syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation
,null,
Cells
,PubMed ID 35053353
[WNT5A]
|
Role of Wnt5a in suppressing invasiveness of hepatocellular carcinoma via epithelial-mesenchymal transition
,Wakizaka, K;Kamiyama, T;Wakayama, K;Orimo, T;Shimada, S;Nagatsu, A;Kamachi, H;Yokoo, H;Fukai, M;Kobayashi, N;Mitsuhashi, T;Taketomi, A;,
Oncology letters
,PubMed ID 32989402
[WNT5A]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...